Fulgent Genetics Inc (NASDAQ:FLGT) has been given a consensus broker rating score of 3.00 (Hold) from the two brokers that cover the company, Zacks Investment Research reports. Two analysts have rated the stock with a hold rating. Fulgent Genetics’ rating score has declined by 50% in the last 90 days as a result of various analysts’ upgrades and downgrades.
Brokerages have set a 1-year consensus price target of $4.35 for the company and are anticipating that the company will post ($0.05) EPS for the current quarter, according to Zacks. Zacks has also given Fulgent Genetics an industry rank of 187 out of 265 based on the ratings given to related companies.
FLGT has been the subject of a number of recent analyst reports. Credit Suisse Group dropped their price objective on Fulgent Genetics from $6.50 to $6.00 and set an “outperform” rating for the company in a report on Thursday, March 1st. Zacks Investment Research upgraded Fulgent Genetics from a “strong sell” rating to a “hold” rating in a report on Tuesday, January 9th. Finally, Piper Jaffray Companies cut Fulgent Genetics from an “overweight” rating to a “neutral” rating in a report on Thursday, March 1st.
Fulgent Genetics (NASDAQ:FLGT) traded up $0.03 during trading hours on Wednesday, reaching $3.85. The company’s stock had a trading volume of 1,987 shares, compared to its average volume of 13,188. The company has a market cap of $68.53 and a P/E ratio of -25.67. Fulgent Genetics has a 1-year low of $2.72 and a 1-year high of $11.80.
Fulgent Genetics Company Profile
Fulgent Genetics, Inc is a technology company. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. The Company has developed a technology platform that integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory processes.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Fulgent Genetics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fulgent Genetics and related companies with MarketBeat.com's FREE daily email newsletter.